A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects

NCT03121716 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

BIOLOGICAL: SHR-1210
DRUG: Gemcitabine
DRUG: cis-platinum

Sponsor

Jiangsu HengRui Medicine Co., Ltd.